JENNIFER FOSTER to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications JENNIFER FOSTER has written about Xenograft Model Antitumor Assays.
Connection Strength
0.263
-
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. J Pathol. 2021 09; 255(1):52-61.
Score: 0.141
-
Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer Lett. 2019 08 10; 457:129-141.
Score: 0.122